Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 56 (-6.7%)Axles India₹ 505 (-3.8%)Bira ₹ 88 (-18.5%)CIAL ₹ 438 (0%)CSK ₹ 264 (0%)ESDS Software₹ 448 (0.7%)Garuda Aerospace₹ 478 (-1.4%)Hero Fincorp₹ 1045 (-0.5%)HPX India₹ 28 (-3.4%)Incred Holdings₹ 150 (-1.3%)India Carbon₹ 895 (0%)Indian Potash₹ 2850 (0%)Inox Clean₹ 725 (-3.3%)Insolare Energy₹ 185 (0%)Lava ₹ 52 (8.3%)Matrix Gas₹ 15 (-6.2%)Motilal Oswal₹ 12.5 (4.6%)MSEI ₹ 6.25 (-3.8%)NCDEX ₹ 384 (-5.2%)NeRL ₹ 56 (-3.4%)NSE ₹ 2045 (6.2%)Onix Renewable₹ 59 (-18.1%)Orbis Financial₹ 425 (4.9%)OYO ₹ 24 (0%)OYO Assets₹ 12 (0%)Pharmeasy ₹ 6.25 (8.7%)Polymatech Electronics₹ 62 (0%)RRP S4E₹ 168 (0%)SBI Mutual₹ 775 (0%)Taparia Tools₹ 6050 (0%)Ticker Ltd₹ 32 (0%)Zepto ₹ 48 (-4%)

15 Days Price Change

Hamps Bio IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds

WEBSITE Inc. Year: 2007 Industry: Trading Listed Page

Profile
Issue Size --
Profile
Price Range 51  to  51 per share
Profile
Min Investment ₹51
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus --
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Founded in 2007, Hamps Bio Limited specializes in the marketing and distribution of a diverse range of pharmaceutical products, including tablets, syrups, capsules, injectables, oils, and nutritional supplements. The company reaches a broad customer base through a network of over 50 distributors and e-commerce platforms such as Amazon (in the US, Canada, and the EU), Flipkart, and Jio Mart. Hamps Bio's pharmaceutical products are sold across 8 states and union territories, while its Freeze-dried and Frozen products are available in 6 countries and 22 states and union territories. The company operates in two key segments: Pharmaceuticals, under the "Hamps" brand, and Freeze-dried and Frozen products, marketed under the "FzyEzy" brand. Its FMCG division offers freeze-dried and frozen food items such as strawberry, jamun, mango, beet powder, and chikoo powder, through both B2B and B2C models, including contract manufacturing. Hamps Bio boasts a portfolio of over 180 products across both segments and a workforce of 78 employees as of October 31, 2024. The company’s competitive strengths include expert leadership, a robust distribution network with a strong e-retailing presence, a wide and diversified product range, a global customer base with long-standing relationships, and a solid brand identity. Read More

Basic Info

Face Value 10 per share

Price 51  to  51 per share

P/E (x) 72.9

Sales( Cr.) 7

PAT( Cr.) 0

EPS 0.7

Draft Prospectus --

Exchange BSE-SME

Promoter

Company Promoters

Herrik Shah Shrenik Shah Pallavi Shah Mitali Shah

Pre Issue Share Holding 100%

Post Issue Share Holding 74.04%

Listing Details:

Listing Price: 48.45

Listing Gain: -5.26%

Current Price: 25.3

Gain On Issue: 25.3 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date Dec 13, 2024
Closing Date Dec 17, 2024
Allotment Dec 18, 2024
Refund Dec 19, 2024
Delivery of Shares Dec 19, 2024
Listing Date Dec 20, 2024

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 2000 102,000
Retail (Max) 1 2000 102,000
S-HNI (Min) 2 4000 204,000
S-HNI (Max) 9 18000 918,000
B-HNI (Min) 10 20000 1,020,000

Objective of the Issue

1. Purchase of plant & amp amp amp amp amp amp amp amp machinery for FMCG division 2. Enhancing the visibility and awareness of the brand 3. General corporate purposes

Issue

Category Nos Bid Bid (x)
QIB 0 0 0x
NII 610000 462544700 758.3x
Retail 610000 818644400 1342x
EMP 0 0 0x
Total 1220000 1289540000 1057x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Hamps Bio Profit & Loss

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 5 6 6 7
Other Income 0 0 0 0
Total Income 5 6 7 7
Total Expenditure 5 5 5 6
Operating Profit 1 1 1 1
Interest 0 0 0 0
Depreciation 0 0 0 0
Exceptional Income / Expenses 0 0 0 0
Profit Before Tax 0 0 1 0
Provision for Tax -0 -0 0 0
Profit After Tax 0 0 1 0
Adjustments 0 0 0 0
Profit After Adjustments 0 0 1 0
Adjusted Earnings Per Share 0.3 0.7 0.8 0.3

Hamps Bio Balance Sheet

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 1 1 3 9
Minority's Interest 0 0 0 0
Borrowings 1 0 0 2
Other Non-Current Liabilities 0 0 0 0
Total Current Liabilities 2 2 1 2
Total Liabilities 4 4 5 13
Fixed Assets 2 3 3 2
Other Non-Current Assets 0 0 0 6
Total Current Assets 1 1 2 4
Total Assets 4 4 5 13

Hamps Bio Cash Flow

#(Fig in Cr.) Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 0 0 0
Cash Flow from Operating Activities 0 1 -0 -2
Cash Flow from Investing Activities 1 -1 -0 -6
Cash Flow from Financing Activities -1 -0 1 8
Net Cash Inflow / Outflow -0 -0 0 0
Closing Cash & Cash Equivalent 0 0 0 0

Hamps Bio Ratios

# Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 0.25 0.75 0.8 0.34
CEPS(Rs) 0.93 1.45 1.44 0.77
DPS(Rs) 0 0 0 0
Book NAV/Share(Rs) 2.1 2.84 5.33 10.1
Core EBITDA Margin(%) 11.52 15.53 18.18 11.54
EBIT Margin(%) 5.51 9.58 12.35 8.15
Pre Tax Margin(%) 1.96 6.4 10.04 6.06
PAT Margin (%) 2.28 6.44 7.73 4.46
Cash Profit Margin (%) 8.36 12.51 13.96 10.12
ROA(%) 3.37 9.53 11.15 3.35
ROE(%) 12.08 30.31 21.27 4.9
ROCE(%) 9.66 17.38 21.35 6.73
Receivable days 47.2 47.45 49.29 59.7
Inventory Days 38.87 30.62 44.96 98.74
Payable days 63.71 90.36 84.03 83.68
PER(x) 0 0 0 62.55
Price/Book(x) 0 0 0 2.12
Dividend Yield(%) 0 0 0 0
EV/Net Sales(x) 0.65 0.57 0.46 3.22
EV/Core EBITDA(x) 5.64 3.65 2.45 23.35
Net Sales Growth(%) 0 4.45 16.08 2.99
EBIT Growth(%) 0 81.52 49.63 -32.05
PAT Growth(%) 0 195.47 39.44 -40.53
EPS Growth(%) 0 195.47 6.72 -57.19
Debt/Equity(x) 2.03 1.27 0.31 0.34
Current Ratio(x) 0.74 0.59 1.74 2.26
Quick Ratio(x) 0.42 0.42 0.86 0.99
Interest Cover(x) 1.55 3.01 5.34 3.89
Total Debt/Mcap(x) 0 0 0 0.16

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 17% 12% 0% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR -100% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 18% NA% NA% NA%
ROE Average 5% 19% 17% 17%
ROCE Average 7% 15% 14% 14%

Company Contact Information

Hamps Bio Ltd.

2900/112, G I D C Near Atul Limited Ankleshwar

IPO Lead Manager(s)

Hamps Bio Ltd.

Marwadi Chandarana Intermediaries Brokers Pvt Ltd.

Registrar Info

Hamps Bio Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!